Skip navigation

DSpace

機構典藏 DSpace 系統致力於保存各式數位資料(如:文字、圖片、PDF)並使其易於取用。

點此認識 DSpace
DSpace logo
English
中文
  • 瀏覽論文
    • 校院系所
    • 出版年
    • 作者
    • 標題
    • 關鍵字
    • 指導教授
  • 搜尋 TDR
  • 授權 Q&A
    • 我的頁面
    • 接受 E-mail 通知
    • 編輯個人資料
  1. NTU Theses and Dissertations Repository
  2. 醫學院
  3. 牙醫專業學院
  4. 臨床牙醫學研究所
請用此 Handle URI 來引用此文件: http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64463
完整後設資料紀錄
DC 欄位值語言
dc.contributor.advisor陳信銘
dc.contributor.authorChia-Yu Wongen
dc.contributor.author翁佳瑜zh_TW
dc.date.accessioned2021-06-16T17:48:41Z-
dc.date.available2015-09-17
dc.date.copyright2012-09-17
dc.date.issued2012
dc.date.submitted2012-08-14
dc.identifier.citation1. Boyle P, Levi B: World cancer report. Edited by International Agency for Research on Cancer (IARC), 2008.
2. Gnepp DR: Diagnostic surgical pathology of the head and neck. Edited by Philadelphia, PA, Saunders/Elsevier, 2009.
3. Warnakulasuriya S: Global epidemiology of oral and oropharyngeal cancer, Oral Oncol 2009, 45:309-316.
4. Cancer Registry Annual Report, 2008 Taiwan. Edited by 2010.
5. Brocklehurst P, Kujan O, Glenny AM, Oliver R, Sloan P, Ogden G, Shepherd S: Screening programmes for the early detection and prevention of oral cancer, Cochrane Database Syst Rev 2010, CD004150.
6. Lingen MW, Kalmar JR, Karrison T, Speight PM: Critical evaluation of diagnostic aids for the detection of oral cancer, Oral Oncol 2008, 44:10-22.
7. Napier SS, Speight PM: Natural history of potentially malignant oral lesions and conditions: an overview of the literature, J Oral Pathol Med 2008, 37:1-10.
8. Warnakulasuriya S, Johnson NW, van der Waal I: Nomenclature and classification of potentially malignant disorders of the oral mucosa, J Oral Pathol Med 2007, 36:575-580.
9. Wang YP, Chen HM, Kuo RC, Yu CH, Sun A, Liu BY, Kuo YS, Chiang CP: Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications, J Oral Pathol Med 2009, 38:651-656.
10. Hsue SS, Wang WC, Chen CH, Lin CC, Chen YK, Lin LM: Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital, J Oral Pathol Med 2007, 36:25-29.
11. Amagasa T: Oral premalignant lesions, International Journal of Clinical Oncology 2011, 16:1-4.
12. Thomson PJ: Field change and oral cancer: new evidence for widespread carcinogenesis?, International journal of oral and maxillofacial surgery 2002, 31:262-266.
13. Siar CH, Mah MC, Gill PP: Risk of the contralateral mucosa in patients with oral potentially malignant disorders, Asian Pacific journal of cancer prevention : APJCP 2011, 12:631-635.
14. Regezi JA, Sciubba JJ, Jordan RCK: Oral pathology : clinical pathologic correlations. Edited by St. Louis, Mo., Saunders Elsevier, 2008.
15. Chattopadhyay A: Oral health epidemiology : principles and practice. Edited by Sudbury, Mass., Jones and Bartlett Publishers, 2011.
16. Rajendran R: Oral submucous fibrosis: etiology, pathogenesis, and future research, Bulletin of the World Health Organization 1994, 72:985-996.
17. Robert A. Robinson MD P: Head & Neck Pathology: Atlas for Histologic & Cytologic Diagnosis. Edited by 2009.
18. Chen HM, Chen CT, Yang H, Kuo MY, Kuo YS, Lan WH, Wang YP, Tsai T, Chiang CP: Successful treatment of oral verrucous hyperplasia with topical 5-aminolevulinic acid-mediated photodynamic therapy, Oral Oncol 2004, 40:630-637.
19. van der Waal I: Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management, Oral Oncol 2009, 45:317-323.
20. Neville BW, Day TA: Oral cancer and precancerous lesions, CA: a cancer journal for clinicians 2002, 52:195-215.
21. Lodi G, Sardella A, Bez C, Demarosi F, Carrassi A: Interventions for treating oral leukoplakia, Cochrane Database Syst Rev 2006, CD001829.
22. Lee JJ, Hung HC, Cheng SJ, Chen YJ, Chiang CP, Liu BY, Jeng JH, Chang HH, Kuo YS, Lan WH, Kok SH: Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006, 101:472-480.
23. Reibel J: Prognosis of oral pre-malignant lesions: significance of clinical, histopathological, and molecular biological characteristics, Crit Rev Oral Biol Med 2003, 14:47-62.
24. Pindborg JJ, Murti PR, Bhonsle RB, Gupta PC, Daftary DK, Mehta FS: Oral submucous fibrosis as a precancerous condition, European Journal of Oral Sciences 1984, 92:224-229.
25. Franco EL, Rohan TE: Upper Aerodigestive Tract. Edited by Sankaranarayanan R, Somanathan T. 2002.
26. Johnson NW, Jayasekara P, Amarasinghe AA: Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology, Periodontology 2000 2011, 57:19-37.
27. Petti S: Pooled estimate of world leukoplakia prevalence: a systematic review, Oral Oncol 2003, 39:770-780.
28. Gorsky M, Epstein JB: Oral lichen planus: malignant transformation and human papilloma virus: a review of potential clinical implications, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011, 111:461-464.
29. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axell T, Bruce AJ, Carpenter W, Eisenberg E, Epstein JB, Holmstrup P, Jontell M, Lozada-Nur F, Nair R, Silverman B, Thongprasom K, Thornhill M, Warnakulasuriya S, van der Waal I: Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007, 103 Suppl:S25 e21-12.
30. Lee JJ, Hong WK, Hittelman WN, Mao L, Lotan R, Shin DM, Benner SE, Xu XC, Lee JS, Papadimitrakopoulou VM, Geyer C, Perez C, Martin JW, El-Naggar AK, Lippman SM: Predicting cancer development in oral leukoplakia: ten years of translational research, Clin Cancer Res 2000, 6:1702-1710.
31. Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP: Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome, Cancer Res 2005, 65:8017-8021.
32. Smith J, Rattay T, McConkey C, Helliwell T, Mehanna H: Biomarkers in dysplasia of the oral cavity: a systematic review, Oral Oncol 2009, 45:647-653.
33. Zhang L, Rosin MP: Loss of heterozygosity: a potential tool in management of oral premalignant lesions?, J Oral Pathol Med 2001, 30:513-520.
34. Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT: Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases, Histopathology 2011.
35. Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, Moller H: Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England, J Oral Pathol Med 2011.
36. Schepman KP, van der Meij EH, Smeele LE, van der Waal I: Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands, Oral Oncol 1998, 34:270-275.
37. Liu W, Bao ZX, Shi LJ, Tang GY, Zhou ZT: Malignant transformation of oral epithelial dysplasia: clinicopathological risk factors and outcome analysis in a retrospective cohort of 138 cases, Histopathology 2011, 59:733-740.
38. Kujan O, Oliver RJ, Khattab A, Roberts SA, Thakker N, Sloan P: Evaluation of a new binary system of grading oral epithelial dysplasia for prediction of malignant transformation, Oral Oncol 2006, 42:987-993.
39. Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E: Oral epithelial dysplasia classification systems: predictive value, utility, weaknesses and scope for improvement, J Oral Pathol Med 2008, 37:127-133.
40. Saito T, Sugiura C, Hirai A, Notani K, Totsuka Y, Shindoh M, Fukuda H: Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality, International journal of oral and maxillofacial surgery 2001, 30:49-53.
41. Mehanna HM, Rattay T, Smith J, McConkey CC: Treatment and follow-up of oral dysplasia - a systematic review and meta-analysis, Head Neck 2009, 31:1600-1609.
42. Lingen MW, Pinto A, Mendes RA, Franchini R, Czerninski R, Tilakaratne WM, Partridge M, Peterson DE, Woo SB: Genetics/epigenetics of oral premalignancy: current status and future research, Oral Dis 2011, 17 Suppl 1:7-22.
43. Lin HP, Chen HM, Yu CH, Yang H, Wang YP, Chiang CP: Topical photodynamic therapy is very effective for oral verrucous hyperplasia and oral erythroleukoplakia, J Oral Pathol Med 2010, 39:624-630.
44. Yang SW, Tsai CN, Lee YS, Chen TA: Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the factors affecting recurrence, J Oral Maxillofac Surg 2011, 69:e78-87.
45. Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C: Photodynamic therapy outcome for oral dysplasia, Lasers Surg Med 2011, 43:192-199.
46. Jerjes W, Upile T, Hamdoon Z, Al-Khawalde M, Morcos M, Mosse CA, Hopper C: CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation, Lasers Med Sci 2012, 27:169-179.
47. Holmstrup P, Vedtofte P, Reibel J, Stoltze K: Long-term treatment outcome of oral premalignant lesions, Oral Oncol 2006, 42:461-474.
48. Angadi PV, Rao S: Management of oral submucous fibrosis: an overview, Oral and maxillofacial surgery 2010, 14:133-142.
49. Lodi G, Scully C, Carrozzo M, Griffiths M, Sugerman PB, Thongprasom K: Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation, Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005, 100:164-178.
50. Lin HP, Chen HM, Cheng SJ, Yu CH, Chiang CP: Cryogun cryotherapy for oral leukoplakia, Head Neck 2011.
51. Yu CH, Chen HM, Chang CC, Hung HY, Hsiao CK, Chiang CP: Cotton-swab cryotherapy for oral leukoplakia, Head Neck 2009, 31:983-988.
52. Edge SB, Byrd DR: AJCC Cancer Staging Manual. Edited by Springer, 2009.
53. Liu W, Wang YF, Zhou HW, Shi P, Zhou ZT, Tang GY: Malignant transformation of oral leukoplakia: a retrospective cohort study of 218 Chinese patients, BMC Cancer 2010, 10:685.
54. Yen AM, Chen SC, Chang SH, Chen TH: The effect of betel quid and cigarette on multistate progression of oral pre-malignancy, J Oral Pathol Med 2008, 37:417-422.
dc.identifier.urihttp://tdr.lib.ntu.edu.tw/jspui/handle/123456789/64463-
dc.description.abstract背景
口腔癌前病變 (OPMDs) 指的是比正常口腔黏膜有較高可能發展成口腔鱗狀細胞癌(OSCC)之所有口腔病變。本實驗的目的是比較不同病理診斷之OPMD的自然發展過程,並希望能根據不同的病理診斷找出可有效減少發生惡性轉變的治療方法。
實驗方法
本實驗為一回溯性世代研究,病人來源1997年6月至2008年12月間來國立台灣大學附設醫院就診,並為經切片確診為OPMD者,其回診狀況記錄至2010年12月止。從病歷上記錄這些病人相關的臨床和病理學上的資料,如生日、性別、是否有抽菸、喝酒,及嚼食檳榔的習慣、臨床診斷,病理診斷,及接受過的治療。病理診斷之上皮變異程度以無變異、輕度、中度或重度上皮變異記之。欲觀察的結果為惡性腫瘤的發生。為避免已有口腔惡性腫瘤但在切片時未取樣到的狀況,病人在初次切片後六個月才會進入到研究的樣本之中。統計分析採用Kaplan–Meier estimates及Cox proportional hazard regression 來探討相關因子和惡性轉變時間的關係。
結果
本實驗的樣本數為2193人,其中以男性居多(84.5%),有84.4%的人大於33歲。在OPMD的病理分類中,squamous hyperplasia是最常見的診斷(48.1%),另外32.5%有上皮變異(分級為嚴重者有45人,中度者346人,輕度者321人)。在約13年的追蹤時間裡,168位病人(7.7%)發現有口腔癌。OPMD的組織學診斷和發生惡性轉變的時間在校正過後仍有相關性。診斷為疣狀增生(verrucous hyperplasia)或上皮變異程度為中度或重度者,其危險(hazard)較上皮無變異者為高(危險比分別為4.1、3.7,及5.2)。另接受手術刀切除OPMD者與未接受手術者相比,其惡性轉變的時間較長,其校正後的危險比為0.4。若再將OPMD的病人依病理診斷來分組,對無上皮變異、上皮變異程度為輕度到中度,及疣狀增生者而言,接受手術刀切除能有效的降低其與未接受手術者的危險比。
結論
OPMD可依據其惡性轉變時間之風險分為低危險組(包含無上皮變異及輕度上皮變異者)及高危險組(包含中度至重度上皮變異及疣狀增生者)。由於這兩組之患者都有在日後發展出口腔癌的危險,若將其手術切除能有效降低這兩組患者發生惡性轉變的風險比。
zh_TW
dc.description.abstractBackground
Oral potentially malignant disorders (OPMDs) were all clinical presentations that carry a risk of developing oral squamous cell carcinoma (OSCC). The aim of the study was to identify the natural history of OPMDs with different histological diagnosis, and correlate the outcome of malignant development with interventions corresponded to histological diagnosis in patient with OPMDs.
Material and method
The retrospective cohort study included patients with biopsy-confirmed OPMDs seen at National Taiwan University Hospital from July 1997 to June 2008 and followed until December 2010. The patients’ clinical and medical variables were identified from medical record, including date of birth, gender, personal habit, clinical presentation of OPMD, histological diagnosis with degree of epithelial dysplasia graded as none, mild, moderate or severe, and management. The outcome of interest was transformation to oral squamous cell carcinoma or oral verrucous carcinoma. To avoid co-existing malignancies, subjects were included 6 months after the date of the index biopsy. Kaplan–Meier estimates and Cox proportional hazard regression were undertaken to explore the simultaneous effects of multiple factors associated with transformation to oral cancer.
Result
There were 2193 patients included in the study. The majority of patients were men (84.5%), and 84.4% were over 33 years of age. Among all OPMDs, squamous hyperplasia was the most common histological diagnosis (48.1%), and 712 (32.5%) had oral epithelial dysplasia (45 severe, 346 moderate and 321 mild). One hundred and sixty-eight patients (7.7%) developed oral cancer over the follow-up period of 13 years. There was an association between histological diagnosis and time to transformation after adjustment. Patients with oral verrucous hyperplasia or moderate or severe dysplasia had higher hazard of transformation to oral cancer compared to those without dysplasia (HR were 4.1, 3.7, and 5.2, respectively). The association between blade surgery and time to transformation was also significant although attenuated (HR was 0.4). This significance of decreased hazard remained for patients who were diagnosed as having no dysplasia, mild to moderate dysplasia, and verrucous dysplasia.
Conclusion
OPMD lesions can be categorized as group with lower hazard (no dysplasia and mild dysplasia) and group with higher hazard (moderate to severe dysplasia and verrucous hyperplasia) to malignant transformation. Since both of them are at risk of developing cancer, blade surgery should be performed to reduce the hazard of malignant transformation.
en
dc.description.provenanceMade available in DSpace on 2021-06-16T17:48:41Z (GMT). No. of bitstreams: 1
ntu-101-R99422029-1.pdf: 547995 bytes, checksum: fb3ad121db064ba0fbb52c18b14f08a4 (MD5)
Previous issue date: 2012
en
dc.description.tableofcontents誌謝 i
CONTENTS ii
LIST OF FIGURES iv
LIST OF TABLES v
中文摘要 vi
ABSTRACT viii
Chapter 1 Introduction 1
1.1 The Epidemiology of Oral Cancer 1
1.2 Oral Potentially Malignant Disorders (OPMDs) 2
1.2.1 Terminology 3
1.2.2 Diagnosis of OPMDs 4
1.2.3 Correlations between OPMDs and Histological Findings 6
1.3 Malignant transformation of OPMDs 8
1.3.1 Potential of malignant transformation in OPMDs 8
1.3.2 Predictors of Malignant Transformation of OPMDs 9
1.4 Treatment Modalities of OPMDs 11
1.5 Research Approach and Significance 12
Chapter 2 Materials and Methods 14
2.1 Selection of Subjects 14
2.2 Statistical Analysis 16
Chapter 3 Results 17
3.1 Descriptive demography 17
3.2 Survival analysis for OSCC-free status 18
3.2.1 Clinical predictors 19
3.2.2 Prognostic value of diagnosis 20
3.2.3 Effectiveness of treatment modalities 20
Chapter 4 Discussion 22
4.1 Principal Findings 22
4.1.1 Clinical risk factors of malignant transformation 23
4.1.2 Natural history of diagnostic categories 24
4.1.3 Effectiveness of treatment modalities 26
4.2 Limitations of this study 27
Chapter 5 Conclusion 28
Chapter 6 Tables and figures 29
REFERENCE 38
dc.language.isoen
dc.subject口腔癌前病變zh_TW
dc.subject疣狀增生zh_TW
dc.subject惡性轉變zh_TW
dc.subject口腔癌zh_TW
dc.subject治療zh_TW
dc.subject上皮變異zh_TW
dc.subjecttreatmenten
dc.subjectdysplasiaen
dc.subjectverrucous hyperplasiaen
dc.subjectoral canceren
dc.subjecttransformationen
dc.subjectoral potentially malignant disordersen
dc.title口腔癌前病變惡性轉變相關之風險因子─台灣之世代研究zh_TW
dc.titleAssociation between Predictors of Oral Potentially Malignant Disorders and Time to Malignant Transformation: a Cohort Study in Taiwanen
dc.typeThesis
dc.date.schoolyear100-2
dc.description.degree碩士
dc.contributor.oralexamcommittee洪信嘉,江俊斌
dc.subject.keyword口腔癌前病變,上皮變異,疣狀增生,口腔癌,惡性轉變,治療,zh_TW
dc.subject.keywordoral potentially malignant disorders,dysplasia,verrucous hyperplasia,oral cancer,transformation,treatment,en
dc.relation.page43
dc.rights.note有償授權
dc.date.accepted2012-08-14
dc.contributor.author-college牙醫專業學院zh_TW
dc.contributor.author-dept臨床牙醫學研究所zh_TW
顯示於系所單位:臨床牙醫學研究所

文件中的檔案:
檔案 大小格式 
ntu-101-1.pdf
  未授權公開取用
535.15 kBAdobe PDF
顯示文件簡單紀錄


系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。

社群連結
聯絡資訊
10617臺北市大安區羅斯福路四段1號
No.1 Sec.4, Roosevelt Rd., Taipei, Taiwan, R.O.C. 106
Tel: (02)33662353
Email: ntuetds@ntu.edu.tw
意見箱
相關連結
館藏目錄
國內圖書館整合查詢 MetaCat
臺大學術典藏 NTU Scholars
臺大圖書館數位典藏館
本站聲明
© NTU Library All Rights Reserved